Ablynx N.V.
Industry
- Biotechnology
- Large Molecule
- Antibodies
- Large Molecule
- Pharmaceuticals
- Drug Delivery
- Macromolecule
- Drug Delivery
Other Names/Subsidiaries
- Ablynx NV
Latest on Ablynx N.V.
Japan has given the first approval anywhere globally to Daiichi Sankyo Co., Ltd. ’s dual inhibitor of EZH1 (enhancer of zeste homolog 1) and EZH2 Ezharmia (valemetostat; DS-3201), for the treatment o
Sanofi 's approach to drug discovery and early pipeline development has been changing over the last five years, and global head of research and chief scientific officer Frank Nestle said in an intervi
Who: Sanofi and Skyhawk Therapeutics, Inc. What: The two companies have signed an exclusive worldwide partnership to discover and develop small molecule drugs in immunology and oncology using Skyha
Sanofi 's approach to drug discovery and early pipeline development has been changing over the last five years, and its global head of research and chief scientific officer Frank Nestle told In Vivo